N-MYC
The expression of the developmentally regulated proto oncogene Pax 3 is modulated by N Myc
11
Potential role of the N-MYC downstream-regulated gene family in reprogramming cancer metabolism under hypoxia
10
Inhibition of cathepsin proteases attenuates migration and sensitizes aggressive N-Myc amplified human neuroblastoma cells to doxorubicin
16
Developmental expression of the N myc downstream regulated gene (Ndrg) family during Xenopus tropicalis embryogenesis
8
Structural basis of N-Myc binding by Aurora-A and its destabilization by kinase inhibitors.
6
c- myc and N- myc promote active stem cell metabolism and cycling as architects of the developing brain
11
Nicotine exposure during differentiation causes inhibition of N-myc expression
13
Otx2 is a target of N myc and acts as a suppressor of sensory development in the mammalian cochlea
9
N-Myc Interactor Inhibits Prototype Foamy Virus by Sequestering Viral Tas Protein in the Cytoplasm
9
Wnt signaling and its downstream target N myc regulate basal progenitors in the developing neocortex
10
N Myc Inhibition: Advances in Neuroblastoma Treatment
8
N-myc downstream-regulated gene 2 (NDRG2) promoter methylation and expression in pituitary adenoma
8
INSM1 increases N-myc stability and oncogenesis via a positive- feedback loop in neuroblastoma
13
N Myc–mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer
18
Myc promotes glutaminolysis in human neuroblastoma through direct activation of glutaminase 2
12
An Amino Acid of Human Parainfluenza Virus Type 3 Nucleoprotein Is Critical for Template Function and Cytoplasmic Inclusion Body Formation
14
Neuroblastoma Represents Distinct Clinical-Biologic Entities: A Review and Perspective From the Quebec Neuroblastoma Screening Project
7
Identification of Two Functional Domains within the Arenavirus Nucleoprotein
12
myc family oncogene amplification in tumor cell lines established from small cell lung cancer patients and its relationship to clinical status and course
7
A moving target: structure and disorder in pursuit of Myc inhibitors
13